The losses and job cuts for Tritium are a concern. While they appear to be opening up new markets that also says that they haven't got a hold on expenses and this may flow on to RFT.
I don't see the R&D facility as a threat to RFT. Why wouldn't they invite a strategic partner to participate at in their R&D?
In the meantime, Rectifier need to look at new opportunities and diversifying into different market sectors to sure up their business if the relationship with Tritium falters.
Chargepoint, page-20
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RFT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.0¢ |
Change
0.001(11.1%) |
Mkt cap ! $13.81M | |||
| Open | High | Low | Value | Volume |
| 0.8¢ | 1.0¢ | 0.8¢ | $1.725K | 205.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 259999 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.0¢ | 1032493 | 5 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| RFT (ASX) Chart |